<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01338922</url>
  </required_header>
  <id_info>
    <org_study_id>PUMPKIN</org_study_id>
    <secondary_id>WA 2929/2-1/ AOBJ 582855</secondary_id>
    <nct_id>NCT01338922</nct_id>
  </id_info>
  <brief_title>Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)</brief_title>
  <acronym>pumpkin</acronym>
  <official_title>Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 DM - a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roche Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Luebeck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of change in diabetes treatment from multiple daily insulin injection therapy to
      continuous subcutaneous insulin infusion on psychosocial outcome measures (quality of life,
      diabetes burden, parents stress level, fear, family conflicts) in families with children and
      adolescents with diabetes mellitus type 1 have been analysed. Additionally the effect on
      metabolic parameters (HbA1c, severe Hypoglycemia, Ketoacidosis) have been analysed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children and adolescents currently treated with MDI and with an indication for CSII were
      randomized 1:1 to either starting with CSII as soon as possible or to continuing MDI while
      waiting six months for transmission to CSII, stratified by center. The primary outcomes were
      patient-reported diabetes-specific health-related quality of life , and diabetes burden of
      the main caregiver. We also investigated the impact of CSII on main caregiver stress,
      psychological well-being, fear of hypoglycemia, main caregiver's and adolescent's treatment
      satisfaction, family conflict, and HbA1c.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>open multicentre parallel randomised controlled intervention trial with waiting-list-control-group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health related quality of life (HRQOL) (patient)</measure>
    <time_frame>6 months</time_frame>
    <description>Child's HRQOL will be measured using the well-known standardized KINDL-R (KINDL) modular questionnaire. The widely used instrument provides a generic age-appropriate core-measure (24 items) and a diabetes-specific module (21 items).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diabetes burden (main carer)</measure>
    <time_frame>6 months</time_frame>
    <description>The main carer (parent) will report on the Overall Diabetes Burden using a one-dimensional 5-point intensity scale which was used in the pilot-study and showed sensitivity to change.
Comment: Two primary measures are used because independent information from the child (patient) and the main carer is requested</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parental stress level</measure>
    <time_frame>6 months</time_frame>
    <description>Parental stress will be measured using the Paediatric Inventory for Parents (PIP). The 42-items instrument provides a Total Frequency Score (PIP-F), and a Total Difficulty Score (PIP-D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypoglycemia fear (main carer)</measure>
    <time_frame>6 months</time_frame>
    <description>Hypoglycemia fear will be measured using the Hypoglycaemia Fear Survey, parent version (HFS-P, Clarke et al. 1998). The 25-items instrument provides two scales: Behaviour and Worry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Family conflicts</measure>
    <time_frame>6 months</time_frame>
    <description>Family conflict (adolescent, main carer) will be measured by the Diabetes Family Conflict Scale (DFCS). The 19 items instrument provides a DFCS Total Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>6 months</time_frame>
    <description>Blood samples will be collected locally with standardised equipment.The mean HbA1c value will be calculated for each patient from the last 3 measurements taken during the past six months. HbA1c values will be mathematically standardized to the Diabetes Control and Complications Trial (DCCT) -equivalent in agreement with published guidelines (Marshall&amp; Barth 2000)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe Hypoglycemia International Society for Pediatric and Adolescent Diabetes (ISPAD) II/III</measure>
    <time_frame>6 months</time_frame>
    <description>Severe hypoglycaemia grade II and grade III will be documented according to ISPAD guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes treatment satisfaction</measure>
    <time_frame>6 months</time_frame>
    <description>Treatment Satisfaction will be measured using the Diabetes Treatment Satisfaction Scale, status version (DTSQs-teen, DTSQs-parent).The validated German version will be released by MAPI (MAPI) in April 2011.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">211</enrollment>
  <condition>Diabetes Mellitus, Insulin-Dependent</condition>
  <arm_group>
    <arm_group_label>Insulin pump therapy (CSII)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous subcutaneous insulin infusion therapy using different devices with marketing approval and different insulins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple daily injection therapy (MDI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Multiple daily injection therapy using different devices with marketing approval and different insulin types</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous subcutaneous insulin infusion therapy</intervention_name>
    <description>Insulin is given continuously using an insulin pump. Devices are allowed having marketing approval. Insulins are permitted with marketing approval.</description>
    <arm_group_label>Insulin pump therapy (CSII)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multiple daily injection therapy</intervention_name>
    <description>Multiple daily injection therapy with different devices and insulin types. Devices and insulin types have to have marketing approval.</description>
    <arm_group_label>Multiple daily injection therapy (MDI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 DM

          -  Transition to Continuous Subcutaneous Insulin Infusion (CSII)

          -  meeting the costs by health services

          -  sufficient German literacy

        Exclusion Criteria:

          -  Remission (diabetes duration &lt; 6 months, insulin &lt; 0.5 i.E./kg)

          -  severe learning problems

          -  Investigator's children

          -  Waiting time not advised for medical reasons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Verena Wagner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endokrinologikum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik Charite</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik für Kinder- und Jugendmedizin, Ruhr-Universität-Bochum</name>
      <address>
        <city>Bochum</city>
        <zip>44791</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PRIMA Kinderkliniken Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <zip>64287</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marienhospital / Kinderklinik</name>
      <address>
        <city>Gelsenkirchen</city>
        <zip>45138</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Gießen</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik am Eichert</name>
      <address>
        <city>Göppingen</city>
        <zip>73035</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderkrankenhaus Wilhelmstift</name>
      <address>
        <city>Hamburg</city>
        <zip>22149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Altonaer Kinderkrankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftskrankenhaus</name>
      <address>
        <city>Herdecke</city>
        <zip>58313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Praxis für Kinder- und Jugendmedizin</name>
      <address>
        <city>Herford</city>
        <zip>32052</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderklinik Städt. Klinikum</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UK-SH, Klinik für Allg. Pädiatrie</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderkrankenhaus Kliniken der Stadt Köln GmbH</name>
      <address>
        <city>Köln</city>
        <zip>50735</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Leipzig, Kinderklinik</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UK SH Campus Lübeck, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ev.Krankenhaus</name>
      <address>
        <city>Oberhausen</city>
        <zip>46047</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinderhospital Osnabrück</name>
      <address>
        <city>Osnabrück</city>
        <zip>49082</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik f. Kinder- und Jugendmedizin</name>
      <address>
        <city>Ravensburg</city>
        <zip>88212</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäts- Kinder- und Jugendklinik</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bethlehem Gesundheitszentrum Stolberg</name>
      <address>
        <city>Stolberg</city>
        <zip>52222</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olgahospital</name>
      <address>
        <city>Stuttgart</city>
        <zip>70176</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72706</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HSK-Kinderklinik</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2011</study_first_submitted>
  <study_first_submitted_qc>April 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2011</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Verena Wagner, MD</investigator_full_name>
    <investigator_title>Verena Wagner MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

